USP22 and hepatocellular carcinoma: Compared with USP22‐NCSH and USP22‐NCOE HCC (Huh‐7 and BEL‐7402) cells, USP22‐SH HCC cells exhibited more sensitive to sorafenib, while USP22‐OE cells were more resistant to sorafenib.